Medeor Therapeutics
PrivateLast Round
Grant
Jan 22, 2018
Total Funding Raised
$75.8M
Company Overview
Medeor Therapeutics is a biotechnology company that develops personalized cellular immunotherapies designed to improve outcomes for organ transplant recipients by inducing immune tolerance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medeor Therapeutics Comparables
Compare Medeor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TolerogenixX GmbH | 89% | |
| Taiwan Bio Therapeutics Inc. | 82% | |
| Sangamo Therapeutics Inc | 77% | |
Medeor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2018 | ||||
| Series B | Nov 27, 2017 |
Medeor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| WuXi Healthcare Ventures | Series B |
| California Institute for Regenerative Medicine | Grant |
| 6 Dimensions Capital | Series B |
| Sofinnova Investments | Series B |
| Vivo Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors grew 92% MoM.
- Nov 6, 2025
Monthly visitors grew 80% MoM, reaching 2.1K.
Medeor Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medeor Therapeutics's valuation, stock price, and market status.